Sorry, you need to enable JavaScript to visit this website.

So far – So good!

You appear to meet the basic requirements for this COVID-19 study. However, only the research study staff can determine if you qualify to enroll. Please enter your contact information and select “Find a Site” to see if there is a study site enrolling in your area. To be eligible, you need to make an appointment as soon as possible and within 5 days of COVID-19 sign/symptom onset.

So far – So good!

You appear to meet the basic requirements for this COVID-19 study. However, only the research study staff can determine if you qualify to enroll. Please enter your contact information and select “Find a Site” to see if there is a study site enrolling in your area. To be eligible, you need to make an appointment as soon as possible and within 4 days after your household member tested positive.

So far – So good!

Thank you for your interest in the real-world data study. Please enter your contact information below and select “Send”.

By selecting “Send” you are agreeing to allow Syneos Health to receive your contact information and authorizing them to contact you via phone number, text or email to discuss the study. Your contact information will not be used for any other purpose.

Data Entry Fields (*Required):

Sorry, you are not eligible at this time...

Thank you for your interest in this COVID-19 study and for answering our questions. We encourage you to enter your information below if you would like to be contacted about future clinical research opportunities. Contact your healthcare provider if you have any medical questions.

Sorry, you are not eligible at this time...

Thank you for your interest in this COVID-19 study and for answering our questions. We encourage you to enter your information below if you would like to be contacted about future clinical research opportunities. Contact your healthcare provider if you have any medical questions.

Sorry, you are not eligible at this time...

Thank you for your interest in this study. Please contact your healthcare provider if you have medical questions.

Thank you for reviewing the study information and answering the questions. If you change your mind later, please return to this website to complete the questionnaire. Please contact your healthcare provider if you have medical questions.

Back to Home

Recently Diagnosed Or Symptomatic Children And Teens At Increased Risk Of Severe Illness From COVID-19

A COVID-19 clinical research study is underway to evaluate the safety and effectiveness of Paxlovid, a potential treatment for children and teens with COVID-19 who have health conditions putting them at risk for severe illness. Answer a few questions to see if the child or teen may be able to participate.

Now Enrolling

Header

A Parent Or Guardian Should Answer The Following Questions On The Child's Behalf.

Question 1 of 4

Do you confirm that you are a parent or guardian of a potential study participant and you are 18 years of age or older?

Question 2 of 4

Is the child or teen between 6 and 17 years of age?

Question 3 of 4

Does the child or teen currently have at least 1 of the following signs or symptoms of COVID-19 and did their symptoms start within the last 5 days?
For a list of COVID-19 symptoms, click here

Question 4 of 4

Does the child or teen have at least 1 characteristic or underlying medical condition that puts them at high risk of developing severe illness from COVID-19?
For a list of underlying conditions, click here

Please select a full valid address.

Choose a Location

Please select a research site near you. If you don't see a site near you, then select "The sites listed here are not convenient for me." Study locations are being added regularly. A study representative will call you if a research site becomes available in your area.

The sites listed here are not convenient for me.

ABOUT THE STUDY FOR CHILDREN AND TEENS WITH COVID-19 AT RISK OF SEVERE ILLNESS

This study is evaluating the safety and effectiveness of Paxlovid, a possible oral treatment for COVID-19 in children and teens. If the child or teen has an underlying medical condition and has at least one sign/symptom of COVID-19, or has been recently diagnosed with COVID-19, this study may be an option.

Who May Participate

Joining a clinical trial is an important and personal decision. Thank you for considering this study. This study may be an option for children and teens who are:

icon

6 to 17 years of age

icon

Having at least one sign/symptom of COVID-19:

  • Cough
  • Shortness of breath or difficulty breathing
  • Fever (documented temperature > 38C (100.4F) or feeling feverish)
  • Chills or shivering
  • Fatigue (low energy or tiredness)
  • Muscle or body aches
  • Diarrhea (loose or watery stools)
  • Vomiting (throwing up)
  • Nausea (feeling like you want to throw up)
  • Headache
  • Sore throat
  • Stuffy or runny nose
icon

Children must be able to swallow tablets and must meet weight requirements.

icon

Having at least 1 of the following characteristics or underlying medical conditions that puts them at risk for severe illness:

  • Immunosuppressive disease (i.e. cancer treatment, HIV, autoimmune disorders)
  • Chronic lung, heart, or kidney disease
  • Sickle cell disease
  • Hypertension (high blood pressure)
  • Active cancer (other than skin cancer)
  • Type 1 or Type 2 diabetes
  • Neurodevelopmental disorder (i.e. cerebral palsy, Downs syndrome)
  • Overweight or obese
  • Current smoker

Note: There are other requirements to participate in this study. A study team member will help determine if this study is right for your family.

Header Image

WHAT TO EXPECT

icon

All participants will receive the study medicine, Paxlovid, which is taken orally twice a day for 5 days (10 total doses).

icon

The child or teen’s participation in the study will last about 5 weeks.

icon

Over the course of 5 weeks, they will need to attend at least 8 study visits. These may include a combination of in-person visits at the clinic or your home, or remote visits over the telephone or computer.

Header Image